Clinicians Need Better Understanding Of Drug-Resistant TB To Maximize Treatment Results, Survey Shows
Center for Global Health Policy’s “Science Speaks”: Multi-country survey sheds light on drug-resistant tuberculosis treatment needs
Antigone Barton, senior editor and writer of “Science Speaks,” discusses a survey published in The Lancet Infectious Diseases that “shows a need for better understanding of the dynamics of drug-resistant [tuberculosis], including through tests that do not yet exist. The survey’s findings … show that tuberculosis that is resistant to the most common first-line drug may often also be resistant to a drug used in substitute therapies…” (7/11).
The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.